New 52 Week Low Today

Axsome Therapeutics Inc AXSM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/09/21 EDT
52.99UNCH (UNCH)
Volume
648
Close
52.99quote price arrow down-1.10 (-2.03%)
Volume
270,358
52 week range
52.84 - 109.53

...

Loading . . .
  • Open53.61
  • Day High54.57
  • Day Low52.84
  • Prev Close54.09
  • 52 Week High109.53
  • 52 Week High Date04/27/20
  • 52 Week Low52.84
  • 52 Week Low Date04/09/21

Key Stats

  • Market Cap1.982B
  • Shares Out37.41M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta2.53
  • YTD % Change-34.96

KEY STATS

  • Open53.61
  • Day High54.57
  • Day Low52.84
  • Prev Close54.09
  • 52 Week High109.53
  • 52 Week High Date04/27/20
  • 52 Week Low52.84
  • 52 Week Low Date04/09/21
  • Market Cap1.982B
  • Shares Out37.41M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta2.53
  • YTD % Change-34.96

RATIOS/PROFITABILITY

  • EPS (TTM)-2.77
  • P/E (TTM)-19.16
  • Fwd P/E (NTM)-12.92
  • EBITDA (MRQ)-99.117M
  • ROE (MRQ)-70.36%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)42.46%

EVENTS

  • Earnings Date05/06/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Axsome Therapeutics Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders, including pain. It operates in the business of developing novel therapies for the management of CNS disorders segment. Its product candidate, AXS-02 (disodium zoledronate tetrahydrate), is an oral, targeted, non opioid therapeutic for chronic pain. It is developing AXS 02 for the treatment of pain...
Herriot Tabuteau M.D.
Chairman
Mark Jacobson
Chief Operating Officer
Nick Pizzie CPA
Chief Financial Officer
Address
22 CORTLANDT STREET, 16TH FLOOR
New York, NY
10007
United States

Top Peers

SYMBOLLASTCHG%CHG
RUBY
Rubius Therapeutics Inc
23.88-0.25-1.04%
KURA
Kura Oncology Inc
28.57+0.24+0.85%
CYDY
Cytodyn Inc
3.13+0.04+1.16%
IBRX
Immunitybio Inc
16.87-1.82-9.74%
RVNC
Revance Therapeutics Inc
28.13+0.38+1.37%